Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology

Journal of Physiology

Volumn 592, Issue 15, 2014, Pages 3189-3200

  Zhang, Yin Hua ^a,b   Jin, Chun Zi ^b   Jang, Ji Hyun ^a   Wang, Yue ^a  

^a Seoul National University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ALTERNATIVE RNA SPLICING; CALCIUM TRANSPORT; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; GENE CONTROL; GENETIC TRANSCRIPTION; HEART CONTRACTION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REPERFUSION INJURY; REVIEW; STELLATE GANGLION; SYSTOLIC DYSFUNCTION; ANIMAL; AUTONOMIC NERVOUS SYSTEM; CALCIUM SIGNALING; CHEMISTRY; ENZYMOLOGY; GENETICS; HEART ARRHYTHMIA; HEART MUSCLE; METABOLISM;

ANIMALS; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; CALCIUM SIGNALING; HUMANS; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE I;

EID: 84905179504     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.270306     Document Type: Review

References (101)

1. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C & Cohen RA (2004). S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10, 1200-1207.
2. Alderton WK, Cooper CE & Knowles RG (2001). Nitric oxide synthases: structure, function and inhibition. Biochem J 357, 593-615.
3. Aquilano K, Baldelli S & Ciriolo MR (2013). Nuclear recruitment of neuronal nitric-oxide synthase by α-syntrophin is crucial for the induction of mitochondrial biogenesis. J Biol Chem 289, 365-378.
4. Aragón JP, Condit ME, Bhushan S, Predmore BL, Patel SS, Grinsfelder DB, Gundewar S, Jha S, Calvert JW, Barouch LA, Lavu M, Wright HM & Lefer DJ (2011). β3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol 58, 2683-2691.
5. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O'Donnell CJ, Hirschhorn JN, Kääb S, Spooner PM, Meitinger T & Chakravarti A (2006). A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38, 644-651.
6. Arnold WP, Mittal CK, Katsuki S & Murad F (1977). Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74, 3203-3207.
7. Baccari MC, Traini C, Garella R, Cipriani G & Vannucchi MG (2012). Relaxin exerts two opposite effects on mechanical activity and nitric oxide synthase expression in the mouse colon. Am J Physiol Endocrinol Metab 303, E1142-E1150.
8. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE & Hare JM (2002). Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339.
9. Belge C, Massion PB, Pelat M & Balligand JL (2005). Nitric oxide and the heart: update on new paradigms. Ann N Y Acad Sci 1047, 173-182.
10. Bendall JK, Damy T, Ratajczak P, Loyer X, Monceau V, Marty I, Milliez P, Robidel E, Marotte F, Samuel JL & Heymes C (2004). Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 110, 2368-2375.
11. Brack KE, Coote JH & Ng GA (2011). Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. Cardiovasc Res 91, 437-446.
12. Brack KE, Patel VH, Mantravardi R, Coote JH & Ng GA (2009). Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J Physiol 587, 3045-3054.
13. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC & Bredt DS (1996). Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84, 757-767.
14. Brennan JP, Bardswell SC, Burgoyne JR, Fuller W, Schröder E, Wait R, Begum S, Kentish JC & Eaton P (2006). Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem 281, 21827-21836.
15. Burger DE, Lu X, Lei M, Xiang FL, Hammoud L, Jiang M, Wang H, Jones DL, Sims SM & Feng Q (2009). Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation 120, 1345-1354.
16. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schröder E, Browning DD & Eaton P (2007). Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317, 1393-1397.
17. Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, Hu K, Hofmann U, Bonz A, Frantz S, Cartwright EJ, Neyses L, Maier LS, Maier SK, Renné T, Schuh K & Ritter O (2007). Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100, e32-44.
18. Burkard N, Williams T, Czolbe M, Blömer N, Panther F, Link M, Fraccarollo D, Widder JD, Hu K, Han H, Hofmann U, Frantz S, Nordbeck P, Bulla J, Schuh K & Ritter O (2010). Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion. Circulation 122, 1588-1603.
19. Chang KC, Barth AS, Sasano T, Kizana E, Kashiwakura Y, Zhang Y, Foster DB & Marbán E (2008). CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signalling in the heart. Proc Natl Acad Sci U S A 105, 4477-4482.
20. Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE 3rd, Papadopoulos V & Snyder SH (2006). NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431-440.
21. Choate JK, Danson EJ, Morris JF & Paterson DJ (2001). Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice. Am J Physiol Heart Circ Physiol 281, H2310-H2317.
22. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cochemé HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RA, Krieg T, Brookes PS & Murphy MP (2013). Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19, 753-759.
23. Coote JH (2005). A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney. Exp Physiol 90, 169-173.
24. Corso-Diaz X & Krukoff TL (2010). nNOSα and nNOSβ localization to aggresome-like inclusions is dependent on HSP90 activity. J Neurochem 114, 864-872.
25. Cunningham MW Jr, Sasser JM, West CA & Baylis C (2013). Renal redox response to normal pregnancy in the rat. Am J Physiol Regul Integr Comp Physiol 304, R443-R449.
26. Damy T, Ratajczak P, Robidel E, Bendall JK, Oliviéro P, Boczkowski J, Ebrahimian T, Marotte F, Samuel JL & Heymes C (2003). Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 17, 1934-1936.
27. Damy T, Ratajczak P, Shah AM, Camors E, Marty I, Hasenfuss G, Marotte F, Samuel JL & Heymes C (2004). Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363, 1365-1367.
28. Danson EJ, Mankia KS, Golding S, Dawson T, Everatt L, Cai S, Channon KM & Paterson DJ (2004). Impaired regulation of neuronal nitric oxide synthase and heart rate during exercise in mice lacking one nNOS allele. J Physiol 558, 963-974.
29. Danson EJ, Choate JK & Paterson DJ (2005). Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharmacol Ther 106, 57-74.
30. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S & Casadei B (2005). nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112, 3729-3737.
31. Doucet MV, Harkin A & Dev KK (2012). The PSD-95/nNOS complex: new drugs for depression? Pharmacol Ther 133, 218-229.
32. Eliasson MJ, Blackshaw S, Schell MJ & Snyder SH (1997). Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci U S A 94, 3396-3401.
33. Feng C, Chen L, Li W, Elmore BO, Fan W & Sun X (2014). Dissecting regulation mechanism of the FMN to heme interdomain electron transfer in nitric oxide synthases. J Inorg Biochem 130, 130-140.
34. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA & Michel T (1996). Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271, 22810-22814.
35. Firestein BL & Bredt DS (1999). Interaction of neuronal nitric-oxide synthase and phosphofructokinase-M. J Biol Chem 274, 10545-10550.
36. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
37. Fusco S, Ripoli C, Podda MV, Ranieri SC, Leone L, Toietta G, McBurney MW, Schütz G, Riccio A, Grassi C, Galeotti T & Pani G (2012). A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc Natl Acad Sci U S A 109, 621-626.
38. Ganzinelli S, Joensen L, Borda E, Bernabeo G & Sterin-Borda L (2007). Mechanisms involved in the regulation of mRNA for M2 muscarinic acetylcholine receptors and endothelial and neuronal NO synthases in rat atria. Br J Pharmacol 151, 175-185.
39. García-Cardeña G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP & Sessa WC (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272, 25437-25440.
40. Gonzalez DR, Beigi F, Treuer AV & Hare JM (2007). Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A 104, 20612-20617.
41. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ & Ignarro L (1979). Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res. 5, 211-224.
42. Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM, Olson SL, Lu WC, Kau CL & Marsden PA (1994). Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269, 33082-33090.
43. Han G, Ma H, Chintala R, Miyake K, Fulton DJ, Barman SA & White RE (2007). Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signalling. Am J Physiol Heart Circ Physiol 293, H314-H321.
44. Heaton DA, Golding S, Bradley CP, Dawson TA, Cai S, Channon KM & Paterson DJ (2005). Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig. J Mol Cell Cardiol 39, 159-164.
45. Herring N & Paterson DJ (2009). Neuromodulators of peripheral cardiac sympatho-vagal balance. Exp Physiol 94, 46-53.
46. Huber-Abel FA, Gerber M, Hoppeler H & Baum O (2012). Exercise-induced angiogenesis correlates with the up-regulated expression of neuronal nitric oxide synthase (nNOS) in human skeletal muscle. Eur J Appl Physiol 112, 155-162.
47. Hyndman KA, Xue J, MacDonell A, Speed JS, Jin C & Pollock JS (2013). Distinct regulation of inner medullary collecting duct nitric oxide production from mice and rats. Clin Exp Pharmacol Physiol 40, 233-239.
48. Idigo WO, Reilly S, Zhang MH, Zhang YH, Jayaram R, Carnicer R, Crabtree MJ, Balligand JL & Casadei B (2012). Regulation of endothelial nitric-oxide synthase (NOS) S-glutathionylation by neuronal NOS: evidence of a functional interaction between myocardial constitutive NOS isoforms. J Biol Chem 287, 43665-43673.
49. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA & Snyder SH (1998). CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20, 115-124.
50. Jaffrey SR & Snyder SH (1996). PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science 274, 774-777.
51. 2+ desensitization mediates positive lusitropic effect of neuronal nitric oxide synthase in left ventricular myocytes from murine hypertensive heart. J Mol Cell Cardiol 60, 107-115.
52. Jin CZ, Jang JH, Wang Y, Kim JG, Bae YM, Shi J, Che CR, Kim SJ & Zhang YH (2012). Neuronal nitric oxide synthase is up-regulated by angiotensin II and attenuates NADPH oxidase activity and facilitates relaxation in murine left ventricular myocytes. J Mol Cell Cardiol 52, 1274-1281.
53. Kinugawa S, Huang H, Wang Z, Kaminski PM, Wolin MS & Hintze TH (2005). A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ Res 96, 355-362.
54. Kohr MJ, Davis JP & Ziolo MT (2009). Peroxynitrite increases protein phosphatase activity and promotes the interaction of phospholamban with protein phosphatase 2a in the myocardium. Nitric Oxide 20, 217-221.
55. Laine R & de Montellano PR (1998). Neuronal nitric oxide synthase isoforms α and μ are closely related calpain-sensitive proteins. Mol Pharmacol 54, 305-312.
56. Li D, Nikiforova N, Lu CJ, Wannop K, McMenamin M, Lee CW, Buckler KJ & Paterson DJ (2013). Targeted neuronal nitric oxide synthase transgene delivery into stellate neurons reverses impaired intracellular calcium transients in prehypertensive rats. Hypertension 61, 202-207.
57. Li Y, Li G, Li C & Zhao Y (2007). Identification of nuclear factor-κB responsive element within the neuronal nitric oxide synthase exon 1f-specific promoter. Acta Biochim Biophys Sin (Shanghai) 39, 247-254.
58. Loyer X, Gómez AM, Milliez P, Fernandez-Velasco M, Vangheluwe P, Vinet L, Charue D, Vaudin E, Zhang W, Sainte-Marie Y, Robidel E, Marty I, Mayer B, Jaisser F, Mercadier JJ, Richard S, Shah AM, Bénitah JP, Samuel JL & Heymes C (2008). Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117, 3187-3198.
59. Massion PB, Feron O, Dessy C & Balligand JL (2003). Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93, 388-398.
60. Masters BS, McMillan K, Sheta EA, Nishimura JS, Roman LJ & Martasek P (1996). Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxylates l-arginine to produce NO as a cellular signal. FASEB J 10, 552-558.
61. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA & Lee-Young RS (2007). Skeletal muscle nNOSμ protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 293, R821-R828.
62. Mohan RM, Choate JK, Golding S, Herring N, Casadei B & Paterson DJ (2000). Peripheral pre-synaptic pathway reduces the heart rate response to sympathetic activation following exercise training: role of NO. Cardiovasc Res 47, 90-98.
63. Moreno C, López A, Llinás MT, Rodríguez F, López-Farré A, Nava E & Salazar FJ (2002). Changes in NOS activity and protein expression during acute and prolonged ANG II administration. Am J Physiol Regul Integr Comp Physiol 282, R31-R37.
64. Nakane M, Schmidt HH, Pollock JS, Forstermann U & Murad F (1993). Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316, 175-180.
65. Niu X, Watts VL, Cingolani OH, Sivakumaran V, Leyton-Mange JS, Ellis CL, Miller KL, Vandegaer K, Bedja D, Gabrielson KL, Paolocci N, Kass DA & Barouch LA (2012). Cardioprotective effect of β-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol 59, 1979-1987.
66. Panda SP, Li W, Venkatakrishnan P, Chen L, Astashkin AV, Masters BS, Feng C & Roman LJ (2013). Differential calmodulin-modulatory and electron transfer properties of neuronal nitric oxide synthase μ compared to the α variant. FEBS Lett 587, 3973-3978.
67. Paton JF, Kasparov S & Paterson DJ (2002). Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci 25, 626-631.
68. Peng HM, Morishima Y, Pratt WB & Osawa Y (2012). Modulation of heme/substrate binding cleft of neuronal nitric-oxide synthase (nNOS) regulates binding of Hsp90 and Hsp70 proteins and nNOS ubiquitination. J Biol Chem 287, 1556-1565.
69. Percival JM, Anderson KN, Huang P, Adams ME & Froehner SC (2010). Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J Clin Invest 120, 816-826.
70. 2+ release in cardiomyocytes. Nat Cell Biol 3, 867-873.
71. Riefler GM & Firestein BL (2001). Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CtBP) changes the localization of CtBP from the nucleus to the cytosol: a novel function for targeting by the PDZ domain of nNOS. J Biol Chem 276, 48262-48268.
72. Saraiva RM, Minhas KM, Raju SV, Barouch LA, Pitz E, Schuleri KH, Vandegaer K, Li D & Hare JM (2005). Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 112, 3415-3422.
73. Sasaki M, Gonzalez-Zulueta M, Huang H, Herring WJ, Ahn S, Ginty DD, Dawson VL & Dawson TM (2000). Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism. Proc Natl Acad Sci U S A 97, 8617-8622.
74. Sasser JM, Moningka NC, Tsarova T & Baylis C (2012). Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade. Life Sci 91, 54-63.
75. Saur D, Seidler B, Paehge H, Schusdziarra V & Allescher HD (2002). Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J Biol Chem 277, 25798-25814.
76. Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, Wallis HL, Neubauer S, Terrar DA & Casadei B (2003). Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92, e52-e59.
77. Seddon M, Melikian N, Dworakowski R, Shabeeh H, Jiang B, Byrne J, Casadei B, Chowienczyk P & Shah AM (2009). Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 119, 2656-2662.
78. Shah AM & MacCarthy PA (2000). Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86, 49-86.
79. 2+/calmodulin binding. Biochem J 355, 357-360.
80. 2+ channel α1 subunit and reduced ischemia/reperfusion injury. Circ Res 98, 403-411.
81. Tain YL, Ghosh S, Krieg RJ & Baylis C (2011). Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model. Pediatr Neonatol 52, 66-72.
82. Tain YL, Muller V, Szabo AJ, Erdely A, Smith C & Baylis C (2008). Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation. Nitric Oxide 18, 80-86.
83. Takimoto Y, Aoyama T, Tanaka K, Keyamura R, Yui Y & Sasayama S (2002). Augmented expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats. Circulation 105, 490-496.
84. Tambascia RC, Fonseca PM, Corat PD, Moreno H Jr, Saad MJ & Franchini KG (2001). Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats. Hypertension 37, 1423-1428.
85. Tobin MD, Kähönen M, Braund P, Nieminen T, Hajat C, Tomaszewski M, Viik J, Lehtinen R, Ng GA, Macfarlane PW, Burton PR, Lehtimäki T & Samani NJ (2008). Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations. Int J Epidemiol 37, 1132-1141.
86. Torres J, Darley-Usmar V & Wilson MT (1995). Inhibition of cytochrome c oxidase in turnover by nitric oxide: mechanism and implications for control of respiration. Biochem J 312, 169-173.
87. Ueda K, Valdivia C, Medeiros-Domingo A, Tester DJ, Vatta M, Farrugia G, Ackerman MJ & Makielski JC (2008). Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A 105, 9355-9360.
88. Vassilakopoulos T, Deckman G, Kebbewar M, Rallis G, Harfouche R & Hussain SN (2003). Regulation of nitric oxide production in limb and ventilatory muscles during chronic exercise training. Am J Physiol Lung Cell Mol Physiol 284, L452-L457.
89. Wang H, Viatchenko-Karpinski S, Sun J, Györke I, Benkusky NA, Kohr MJ, Valdivia HH, Murphy E, Györke S & Ziolo MT (2010). Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation. J Physiol 588, 2905-2917.
90. Wang Y & Marsden PA (1995). Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 34, 71-90.
91. Wang Y, Newton DC & Marsden PA (1999a). Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 13, 21-43.
92. Wang Y, Newton DC, Robb GB, Kau CL, Miller TL, Cheung AH, Hall AV, VanDamme S, Wilcox JN & Marsden PA (1999b). RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Natl Acad Sci U S A 96, 12150-12155.
93. Welter R, Yu L & Yu CA (1996). The effects of nitric oxide on electron transport complexes. Arch Biochem Biophys 331, 9-14.
94. Xia Y, Berlowitz CO & Zweier JL (2006). PIN inhibits nitric oxide and superoxide production from purified neuronal nitric oxide synthase. Biochim Biophys Acta 1760, 1445-1449.
95. Xie J, Roddy P, Rife TK, Murad F & Young AP (1995). Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci U S A 92, 1242-1246.
96. Xu KY, Huso DL, Dawson TM, Bredt DS & Becker LC (1999). Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96, 657-662.
97. Young AP, Murad F, Vaessin H, Xie J & Rife TK (1995). Transcription of the human neuronal nitric oxide synthase gene in the central nervous system is mediated by multiple promoters. Adv Pharmacol 34, 91-112.
98. Zhang YH & Casadei B (2012). Sub-cellular targeting of constitutive NOS in health and disease. J Mol Cell Cardiol 52, 341-350.
99. Zhang YH, Dingle L, Hall R & Casadei B (2009). The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium. Biochim Biophys Acta 1787, 811-817.
100. Zhang YH, Zhang MH, Sears CE, Emanuel K, Redwood C, El-Armouche A, Kranias EG & Casadei B (2008). Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 102, 242-249.
101. Zhou L & Zhu DY (2009). Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 20, 223-230.